GlassScriptPhysician profile
Chanell S Salage
NPI 1275181547
$6,398.62
in general payments reported to CMS, 2019-2025
26 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,319 · 2022: $15.72 · 2023: $919 · 2024: $15.48 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $561 · Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $560.63 |
| Food and Beverage | $503.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $3,379.04 | 2021 | |
| Relievant Medsystems, INC. | $918.99 | 2023 | Intracept |
| Biogen, INC. | $406.25 | 2021 | |
| Emd Serono, INC. | $379.44 | 2021 | |
| Avanir Pharmaceuticals, INC. | $183.20 | 2021 | |
| Novartis Pharmaceuticals Corporation | $152.42 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $146.35 | 2021 | |
| Janssen Pharmaceuticals, INC | $128.98 | 2021 | |
| Medtronic, INC. | $113.08 | 2022-2025 | Intellis Adaptivestim |
| Alexion Pharmaceuticals, INC. | $81.43 | 2021 | |
| Celgene Corporation | $78.06 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $64.13 | 2021 | |
| Genentech USA, INC. | $50.91 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $50.30 | 2021 | |
| Abbvie INC. | $39.78 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $31.85 | 2025 | |
| Amneal Pharmaceuticals LLC | $29.12 | 2021 | |
| Amgen INC. | $26.60 | 2021 | |
| Lilly USA, LLC | $23.22 | 2021 | |
| Ucb, INC. | $21.79 | 2021 | |
| Mallinckrodt Hospital Products INC. | $17.33 | 2021 | |
| Lundbeck LLC | $17.11 | 2021 | |
| Horizon Therapeutics Plc | $15.89 | 2021 | |
| Boston Scientific Corporation | $15.48 | 2024 | Intracept |
| Acadia Pharmaceuticals INC | $14.23 | 2021 | |
| Acorda Therapeutics, INC | $13.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chanell Salage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.